Alberto Bosque

15PUBLICATIONS
29CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 21, 2026
Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.

|May 07, 2026
HIV broadly neutralizing antibodies with enhanced Fc-CD16 affinity increase NK cell ADCC even with limited envelope binding.

|Jan 27, 2026
Retinoids enhance NK effector function against HIV-infected CD4 T cells.

Elyse K McMahon, Jonathan S Lochner, Rebecca M Lynch

|Oct 14, 2024
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.

J Natalie Howard, Callie Levinger, Selase Deletsu

|Sep 28, 2023
IL-15 and N-803 for HIV Cure Approaches.

J Natalie Howard, Alberto Bosque

|Feb 03, 2023
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent.

Preethi B Balakrishnan, Carissa S Holmberg, Debbie K Ledezma

Pageof 3

Frequent Collaborators

1 joint publications

Celsa A Spina

1 joint publications

David M Margolis

1 joint publications

Kimberley L Jones

1 joint publications

Joshua C Cyktor